Home » Newsletters » BioWorld

BioWorld

Nov. 5, 1997

View Archived Issues

SIBIA Public Offering Could Raise $17M For CNS Drugs

Other News To Note

Volatile Market Forces Affymetrix To Pull Offering

Alpha-Beta To Begin Confirmatory Phase III Study Of Betafectin

Action On FDA Reform, User Fees Slated This Week

Scientist Proposes Setting Gene To Find Disease As Alternative Approach